AAD2026:GaldermaShowcasesLatestEvidenceSupportingItsFull-Spectrum,Science-DrivenSolutionsforDiverseSkinNeeds
===2026/3/27 11:38:01===
key biological drivers of skin aging: oxidative stress and cellular senescence. Together, these strategies support a broader vision of skin longevity and resilience over time.
Injectable Aesthetics: Exploring the ability of different treatment modalities to address needs across the face and body
Five e-posters will share the latest development updates from Galderma’s injectable aesthetics portfolio, including data:
On the company’s versatile Restylane hyaluronic acid portfolio, with e-posters on Restylane Lyft™ for augmentation of the chin region, Restylane Shaype™* in enhancing the jawline, Restylane Contour™* in the correction of temple hollowing, and Restylane Skinboosters™* in smoothing wrinkles in the décolletage.10-13
Investigating outcomes with RelabotulinumtoxinA*, Galderma’s ready-to-use liquid neuromodulator manufactured with PEARL™ Technology, across different age groups when treating moderate-to-se
=*=*=*=*=*=
当前为第7/17页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页